Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
TMDX
#1134
TransMedics Group, Inc. Common Stock
145.2
6
+10.61%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+10.61%
Aylık değişim
+4.48%
6 aylık değişim
+22.71%
Yıllık değişim
+95.03%
Önceki kapanış
131.3
3
Open
145.2
6
Bid
Ask
Low
145.2
6
High
145.2
6
Hacim
83
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
TMDX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
33.56 M
33.66 M
33.83 M
34.09 M
34.17 M
34.3 M
—
Valuation ratios
Enterprise value
4.94 B
1.76 B
1.97 B
4.17 B
3.37 B
3.68 B
13.19 B
Price to earnings ratio
167.02
61.73
49.47
69.44
45.43
24.98
189.31
Price to sales ratio
13.48
4.97
5.02
9.54
7.73
8.15
30.43
Price to cash flow ratio
144.55
44.99
47.49
45.3
25.02
25.57
143.38
Price to book ratio
7.77
9.61
2.74
4.96
3.76
10.42
21.88
Enterprise value to EBITDA ratio
100.51
30.78
26.53
41.55
27.76
27.14
122.98
Profitability ratios
Return on assets %
0.01
0.01
0.03
0.04
0.03
0.1
0.19
Return on equity %
0.02
0.03
0.1
0.11
0.07
0.22
0.5
Return on invested capital %
4.11
8.21
23.35
30.18
20.15
-50.15
23.53
Gross margin %
55.94
59.21
61.47
61.38
58.8
58.11
239.76
Operating margin %
3.61
7.11
19.12
23.24
16.2
13.23
71.79
EBITDA margin %
8.37
11.78
23.39
27.51
20.96
17.88
89.75
Net margin %
3.88
5.64
17.89
22.18
16.91
65.55
122.53
Liquidity ratios
Quick ratio
7.33
7.52
8.32
9.17
7.13
6.59
31.21
Current ratio
8.2
8.3
9.1
9.86
7.69
7.14
33.79
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.14
0.15
0.17
0.18
0.16
0.16
0.67
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.65
0.63
0.61
0.57
0.54
0.47
2.19
Long term debt to total equity ratio
2.42
2.23
1.92
1.61
1.43
1.06
6.01
Per share metrics
Operating cash flow per share
0.19
0.56
0.07
2.12
1.71
0.85
4.75
EBIT per share
0.11
0.25
0.69
0.9
0.57
0.52
2.69
EBITDA per share
0.26
0.41
0.84
1.07
0.74
0.71
3.36
Total debt per share
—
—
—
—
—
—
—
Cash per share
9.25
9.56
7.77
9.88
11.44
12.05
41.13
Net current asset value per share
13.8
14.12
12.68
13.76
15.04
15.73
57.21
Tangible book value per share
5.5
6.1
6.33
7.51
8.38
11.34
33.56
Working capital per share
12.12
12.42
11.28
12.36
13.09
13.53
50.26
Book value per share
5.88
6.49
6.67
7.84
8.72
11.67
34.9
Haberler
TransMedics, 4분기 세금 혜택이 수익에 미치는 영향 명확히 밝혀
TransMedics clarifies Q4 tax benefit impact on earnings
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
니덤, TransMedics 목표 주가 $174로 상향 조정
Needham raises TransMedics stock price target to $174 on beat
TransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call Transcript
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
트랜스메딕스, 어닝 서프라이즈 및 견조한 가이던스에 급등
TransMedics surges on earnings beat, solid guidance
Dow Jones Futures: Stock Market Bounces Before Trump Speech, Nvidia Earnings
TransMedics earnings beat by $2.23, revenue topped estimates
투자자들, TransMedics 실적 발표 앞두고 마진 주시